ABL1 and hydrops fetalis: The findings of our disproportionality analysis study present substantial evidence that BCR::ABL1 TKI exposure is associated with the occurrence of pregnancy complications such as hydrops fetalis, polyhydramnios among fetuses or newborns, which were more specific to dasatinib.